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Sensitization to foods often occurs in infancy, without a known prior oral exposure, suggesting that alternative
exposure routes contribute to food allergy. Here, we tested the hypothesis that peanut proteins activate innate
immune pathways in the skin that promote sensitization. We exposed mice to peanut protein extract on undamaged
areas of skin and observed that repeated topical exposure to peanut allergens led to sensitization and anaphylaxis
upon rechallenge. In mice, this epicutaneous peanut exposure induced sensitization to the peanut components Ara h 1
and Ara h 2, which is also observed in human peanut allergy. Both crude peanut extract and Ara h 2 alone served
as adjuvants, as both induced a bystander sensitization that was similar to that induced by the atopic dermatitisassociated staphylococcal enterotoxin B. In cultured human keratinocytes and in murine skin, peanut extract directly
induced cytokine expression. Moreover, topical peanut extract application induced an alteration dependent on the
IL-33 receptor ST2 in skin-draining DCs, resulting in Th2 cytokine production from T cells. Together, our data support
the hypothesis that peanuts are allergenic due to inherent adjuvant activity and suggest that skin exposure to food
allergens contributes to sensitization to foods in early life.

Introduction

IgE-mediated food allergy affects 6%–8% of children, and
although allergies to foods such as milk or egg are frequently
outgrown, allergies to peanut are commonly lifelong and affect
1%–2% of the population (1). Prevalence of peanut allergy is
increasing (2), and reactions to peanut can be severe and occur
at a very low dose. It is difficult to avoid peanut due to many factors, including cross-contamination during food processing. What
makes peanut such a potent allergen is not understood, although
in human in vitro systems it was described that Ara h 1 from peanut could bind to DC-specific ICAM3-grabbing nonintegrin (DCSIGN) in a glycosylation-dependent manner, resulting in a modified DC phenotype and increased capacity for Th2 skewing (3, 4).
Innate recognition of allergens has been described for other clinically relevant allergens, including dust mite allergens that activate
epithelial cells and DCs through TLR4 and dectin-1 (5, 6).
The vast majority of first reactions to peanut and tree nuts
occur on the first known ingestion (7), suggesting that exposure resulting in primary sensitization likely occurred through
another route. There is mixed evidence about a potential role of
exposure to peanut in utero or through breast milk (8, 9). House-
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hold use of peanut, independent of maternal or infant ingestion
of peanut, is a risk factor for development of peanut allergy (10).
Furthermore, peanut antigen is readily detectable in household
dust (11, 12), indicating that environmental exposure to peanut
is likely. Studies on peripheral blood from patients with peanut
allergy demonstrate that peanut-responsive T cells are found
within the fraction bearing the skin-homing receptor CLA (13),
providing support for the hypothesis that initial priming may
have occurred through the skin. Ara h 1–MHC II tetramers identify CD4+ T cells in peanut-allergic subjects that express high
levels of CCR4 (14), another skin-homing receptor, suggesting
that skin exposure may be a highly relevant route of exposure for
peanut sensitization. It is not clear if this is unique to peanut or
may be common to all foods.
Previous studies have shown that epicutaneous exposure of
mice to allergens results in sensitization when skin has been lightly
damaged through tape stripping and that this is downstream of an
altered immune milieu in the skin, including elevated TSLP and
IL-21 (15–17). Tape stripping is a model of excoriation of the skin
analogous to that observed in atopic dermatitis, a condition that
is a risk factor for the development of food allergy. Furthermore,
filaggrin mutations that are associated with defective skin barrier
also convey increased risk for peanut allergy (18). Although food
allergy is a common feature in children with atopic skin inflammation, children with healthy skin also become sensitized to peanut.
We have shown previously that exposure of mice to milk allergens
by the epicutaneous route can induce sensitization, but only in the
jci.org   Volume 124   Number 11   November 2014
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Figure 1. Adjuvant-independent sensitization to peanut through epicutaneous exposure. Mice were topically exposed to 1 mg CPE or soy extract weekly
for 6 weeks. Antigen-specific (A) IgE and (B) IgG1 were measured prior to allergen challenge. Black circles represent values in naive mice, and gray rectangles represent mice exposed to the extract. Mice were challenged with 0.1 mg CPE by intraperitoneal challenge. Body temperature prior to challenge and 30
minutes after the last challenge are shown in C. **P < 0.01.

presence of adjuvant, which was needed to drive dermal DCs to
the draining lymph node (19). Our previous studies indicate that
skin exposure is not inherently sensitizing and that some form
of adjuvant activity is needed to drive sensitization through the
skin. In this study, we show that peanut can induce sensitization
when applied to healthy intact skin and that it does so by activating
innate immunity in the skin, altering the DC phenotype through
mechanisms mediated by the IL-33 receptor ST2, and driving a
Th2-polarized T cell response. Our results with peanut allergen
support the hypothesis that environmental exposure to peanut is
an important risk factor for sensitization.

Results

Adjuvant-independent sensitization to peanut through epicutaneous
exposure. We demonstrated previously that mice can be sensitized
to cow’s milk allergens through the epicutaneous route, but only
in the presence of exogenous adjuvant (19). To determine whether
this adjuvant dependence also applies to the potent food allergen
peanut, we exposed mice to crude protein extracts from peanut.
Soy extract was used as a comparison extract. The major peanut
allergens, Ara h 1, Ara h 2, and Ara h 3, are highly homologous to
proteins found within soy, yet soy allergy is rarely persistent or
severe. Extracts were applied epicutaneously once per week for
6 weeks. Briefly, hair was removed with depilatory cream, but no
tape stripping was performed and antigen was added topically
in PBS without occlusive bandages. Histology of the skin after
hair removal confirmed that the stratum corneum was intact
(data not shown). Mice were then rechallenged and monitored
for a drop in body temperature indicative of anaphylaxis. Mice
exposed to peanut extract developed robust peanut-specific IgE
and IgG1 responses and, when challenged by the intraperitoneal
route with 100 μg peanut extract, developed severe anaphylaxis
(Figure 1). In contrast, mice exposed to soy extract generated
no soy-specific antibodies and did not develop anaphylaxis on
soy challenge. However, when mice were exposed to soy in the
presence of the superantigen staphylococcal enterotoxin B (SEB),
they developed IgE and IgG1 antibody responses to soy (Supplemental Figure 1; supplemental material available online with this
article; doi:10.1172/JCI75660DS1). SEB did not further amplify
the IgE and IgG1 response to peanut but increased the low
IgG2a response observed with peanut alone. In the same exper4966
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iment, milk allergen α-lactalbumin (ALA) exposure was used as
a negative control group, and mice exposed to ALA alone did not
develop ALA-specific IgE and IgG1 responses (data not shown).
To further explore the relationship between known allergenicity
and responses in this mouse model, mice were epicutaneously
exposed to extract from cashew, a tree nut with high allergenicity,
and green bean, a legume with low allergenicity in humans (Supplemental Figure 2). Mice exposed to cashew without exogenous
adjuvant developed cashew-specific IgE and IgG1 responses,
while mice exposed to green bean extract developed IgE and IgG1
responses only in the presence of exogenous adjuvant (cholera
toxin). These results suggest that the response of mice to epicutaneous food allergen exposure is consistent with the allergenicity
of these foods in humans.
To determine whether the process of hair removal contributed
to the sensitization response to peanut, perhaps through emptying of
the hair follicle that is densely surrounded by DCs (20), the experiment was repeated by applying peanut extract to the ear, without any
pretreatment of the skin. Exposure of mice to peanut extract topically
on the ear induced peanut-specific IgE and IgG1 responses, basophil
activation after in vitro allergen stimulation, and anaphylaxis in mice
when rechallenged (Supplemental Figure 3). Altogether, these results
show that peanut, similar to cashew and unlike weak allergens such
as soy, green bean, or milk ALA, is capable of inducing adjuvant-independent sensitization by topical exposure on healthy skin.
We next examined which allergens were recognized in mice
sensitized by the epicutaneous route (Supplemental Figure 4B)
and compared this to the sensitization profile of peanut-allergic
subjects (Supplemental Figure 4A). Immunoblotting of peanut
extract performed with human sera identified 3 bands in the 14- to
20-kDa range, consistent with Ara h 2 (approximately 17 kDa) and
Ara h 6 (approximately 14 kDa). These 3 bands were also detectable in mice epicutaneously exposed to crude peanut extract
(CPE). A higher molecular weight band was also detectable in both
humans and mice, consistent with Ara h 1 (63–68 kDa) or Ara h
3 (57 kDa). Using purified Ara h 1 and Ara h 2, we examined the
contribution of these allergens in mice sensitized to CPE. Mice
exposed to peanut developed detectable IgE antibodies against
both Ara h 1 and Ara h 2 (Supplemental Figure 4C), and basophil
activation tests performed with whole blood from peanut-sensitized mice showed a similar threshold of reactivity to the 2 dom-
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Figure 2. Peanut and Ara h 2 induce bystander sensitization, demonstrating adjuvant activity. (A–C) Mice were exposed to 0.1 mg ALA on the ear,
alone, or in the presence of 10 μg SEB or 1 mg CPE once a week for 6 weeks.
ALA-specific (A) IgE and (B) IgG1 were measured in serum prior to oral
challenge with ALA. (C) Body temperature was measured at baseline and
30 minutes after challenge. n = 5 mice per group. (D–F) The experiment was
repeated with exposure to ALA in the presence or absence of 0.1 mg purified
Ara h 2. n = 4 per group. *P < 0.05, **P < 0.01, ***P < 0.001, vs. ALA alone.

inant allergens (Supplemental Figure 4D). A titrated intraperitoneal challenge of peanut-sensitized mice demonstrated that both
Ara h 1 and Ara h 2 could trigger anaphylaxis, beginning at a dose
of 10 μg, but Ara h 2 induced a stronger anaphylactic reaction than
Ara h 1 (Supplemental Figure 4E).
To determine whether sensitization could also be established
using purified allergens on exposure, we exposed mice to peanut
extract or purified Ara h 1 or Ara h 2 epicutaneously without adjuvant (Supplemental Figure 5). Mice developed marked antibody
responses to the peanut components (Supplemental Figure 5A),
indicating that other components in crude extract are not necessary for sensitization. Despite the induction of antibody responses
to Ara h 1 and Ara h 2, only mice exposed to Ara h 2 experienced
significant anaphylactic reactions following intraperitoneal challenge (Supplemental Figure 5B). Ara h 2 is the component of peanut linked most closely to clinical reactivity in humans (21).
Peanut has adjuvant activity on the skin. Sensitization to antigens after epicutaneous exposure has been shown previously to be
dependent on additional factors, including skin damage (17), presence of inflammation (22), or use of exogenous adjuvants such as
SEB (23) or cholera toxin (19). We hypothesized that peanut could
be inducing “adjuvant-free” sensitization by providing inherent
adjuvant activity. To test this, we examined the capacity of peanut
to induce bystander sensitization to the milk allergen ALA that
we have previously shown is adjuvant dependent (19). Mice were
exposed to ALA alone or in the presence of peanut or SEB as positive control once a week for 6 weeks. Mice exposed to ALA alone

did not have detectable levels of ALA-specific IgE and had low levels
of ALA-specific IgG1 (Figure 2, A and B). Mice exposed to ALA in
the presence of either SEB as adjuvant or peanut developed a significant ALA-specific antibody response, including IgE and IgG1
antibodies (Figure 2, A and B), and to a lesser extent IgG2a (data
not shown). To test the functional consequence of bystander sensitization, mice were challenged with ALA by oral gavage (Figure 2C).
Mice exposed to ALA alone did not undergo anaphylaxis when they
were orally rechallenged with ALA, but when mice exposed to ALA
together with either SEB or peanut were orally rechallenged with
ALA alone, they developed anaphylaxis, as measured by a significant drop in body temperature. We then tested whether Ara h 2, the
dominant allergen in peanut, could induce bystander sensitization.
Similar to the results with CPE, topical exposure to Ara h 2 resulted
in bystander sensitization to ALA (Figure 2, D and E) and anaphylaxis in mice orally challenged with ALA alone (Figure 2F). These
data conclusively demonstrate that peanut, and its major allergen
Ara h 2, have adjuvant activity when applied to the skin.
Peanut induces an innate cytokine response. To determine
whether peanut can induce innate responses in vivo, peanut
extract was applied on the ear, followed by harvesting of tissue
RNA over time (2–24 hours) and assessment of cytokine expression by RT-PCR (Figure 3A). We examined expression of the
cytokines Il1b, Il6, Il33, Il25, and Tslp. These cytokines were chosen since they can alter the phenotype of resident DCs and drive
the adaptive immune response away from one of tolerance. We
observed significant upregulation of Il33 expression and a trend
of increased expression of Il1b but did not observe upregulation
of other Th2-promoting cytokines (Il25, Tslp) or proinflammatory
cytokines. To test whether keratinocytes could directly recognize and respond to peanut exposure, we used primary neonatal
human keratinocytes (Figure 3B). We examined expression of the
cytokines IL1A, IL1B, TNFA, IL6, GMCSF, TSLP, IL25, and IL33
after stimulation with CPE that had been cleaned of endotoxin.
Of these cytokines, IL6 and IL33 were significantly upregulated by
exposure of keratinocytes to peanut extract. IL-6 was confirmed
at the protein level to be released in response to peanut in a dose-
dependent manner (data not shown). Peanut has been shown previously to have direct effects on mouse and human DCs (3, 24).
We stimulated bone marrow–derived DCs with peanut extract and
assessed phenotype by flow cytometry and real-time PCR. Stimulation of cells with peanut extract did not alter the expression of
MHC II, Cd80, or Cd86 or significantly change the expression of
cytokines, including Il1b, Il6, or Il10. However, stimulation with
peanut extract did induce a significant upregulation of Ox40l (Figure 3C), a costimulatory molecule that we and others have previously shown is involved in the induction of Th2 responses after
oral sensitization using cholera toxin adjuvant (25, 26).
jci.org   Volume 124   Number 11   November 2014
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Figure 3. Innate response to epicutaneous peanut exposure. (A) Mice were exposed to peanut or PBS as control on the ear, followed by RNA isolation and
RT-PCR for cytokines. (B) Human keratinocytes or (C) mouse bone marrow DCs were exposed in vitro to CPE or PBS as control. Fold change is shown with respect
to PBS. Relative expression refers to data normalized to the housekeeping gene. Data are mean ± SEM of a least 3 different experiments. *P < 0.05, **P < 0.01.

DCs from peanut-exposed mice are sufficient to drive Th2 priming.
To determine whether epicutaneous peanut exposure modifies the
phenotype of DCs in vivo, resulting in functional consequences
on T cell priming, we purified DCs from the skin-draining lymph
nodes of mice 24 hours after epicutaneous exposure to ovalbumin
(OVA) in the presence or absence of peanut. Purified DCs were
cocultured with OVA-specific CD4+ T cells from DO11.10 mice
at a 1:5 ratio for 3 days, followed by restimulation with anti-CD3/
CD28 to maximize cytokine output. Cytokine secretion was measured by ELISA (Figure 4). DCs harvested from mice epicutaneously exposed to OVA in the presence of peanut induced significantly greater Th2 (IL-4 and IL-5) responses compared with those
from mice exposed to OVA alone, while IL-10 was unchanged.
IL-13, IFN-γ, and IL-17 secretion was elevated but did not reach the
level of statistical significance. CPE alone was used as a negative
control (without OVA to activate the OVA-specific T cells), without significant differences with respect to PBS or OVA alone (data
not shown). These results demonstrate that topical peanut exposure alters the phenotype of skin-draining DCs in vivo, resulting
in an amplification of adaptive immunity, including an elevated
Th2 immune response. Interestingly, the DC-driven increase in
Th2 priming was not observed when we used SEB rather than CPE
as an adjuvant in this model (data not shown), indicating that the
mechanism mediating the induction of Th2 responses is different
depending on the nature of the adjuvant factor.
Induction of Th2 immunity can be driven by peanut or adjuvant,
but only adjuvant induces T follicular helper cells. The generation of
IgE antibodies resulting in clinical food allergy could potentially
be driven by 2 T helper subsets: Th2 cells producing IL-4 and IL-13
and T follicular helper (Tfh) cells. Tfh cells are a subset of CD4+
T cells, which induce immunoglobulin class switching and promote germinal center reactions (27). These cells also secrete low
levels of IL-4, which is required for somatic hypermutation and
4968
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affinity maturation. We hypothesized that peanut or SEB promote
bystander sensitization or self-sensitization by inducing Th2 and/
or Tfh responses. To test whether there was an induction of Th2
immunity after sensitization, 4get mice (which have GFP expression in IL-4–expressing cells) (28) were epicutaneously exposed to
PBS, SEB, or peanut. One week after exposure, the draining lymph
nodes were harvested and assessed for GFP. We observed a significant increase of GFP-positive CD4+ T cells in the skin-draining lymph nodes (Figure 5A) in response to either peanut or SEB.
Induction of reporter activity was restricted to the draining lymph
nodes and was not observed at distal lymph nodes (the mesenteric lymph nodes). GFP reporter activity was observed primarily within the memory T cell population (CD44hiCD4+ cells, data
not shown). We verified the peanut-dependent induction of Th2
responses by using IL-13 reporter mice (IL-13eGFP mice) (29).
An increase in IL-13 reporter activity was also observed in the
skin-draining lymph nodes after epicutaneous exposure to peanut in total CD4+ and CD44hiCD4+ cells (Supplemental Figure 6
and data not shown). Induction of memory Th2 cells is therefore a
common response to exposure to peanut and SEB.
We next wanted to determine whether there was a local
induction of Tfh cells after epicutaneous exposure to peanut or
SEB. CXCR5+ICOS+ cells in the CD4+ population were defined
as the Tfh cell population. Mice exposed to SEB via skin showed
an increased population of CXCR5+ICOS+ cells in skin-draining
lymph nodes within both total CD4+ and CD44hi memory populations (Figure 5B and data not shown). In contrast, mice epicutaneously exposed to peanut did not have an expansion of local
Tfh cells, indicating that SEB induces a broader immune response
than that generated by peanut. IgE class switching has been
reported to occur outside of germinal centers (30); however, we
do not have direct evidence to suggest non-germinal center localization of the peanut-specific IgE response.

The Journal of Clinical Investigation  
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Figure 4. Effect of in vivo exposure to CPE on priming by DCs.
DCs were purified from the skin-draining lymph nodes of BALB/c
mice epicutaneously exposed to PBS, OVA, or OVA and CPE
and cocultured with DO11.10 CD4+ T cells for 3 days, followed
by restimulation with CD3/CD28. Data are mean ± SEM of 7
independent experiments, with each experiment consisting of 3
pooled mice per group. *P < 0.05, **P < 0.01.

IL-1, IL-6, and IL-33 link innate and adaptive immunity in the
skin. We observed that peanut induces an innate cytokine response
from keratinocytes and alters the phenotype of DCs, contributing
to altered T cell priming. We sought to establish a link between the
innate immune response and the adaptive immune response in
vivo. We first blocked cytokines, specifically IL-6 and IL-1, that we
had observed were upregulated in keratinocytes
or skin by peanut exposure. IL-6 was blocked with
neutralizing anti–IL-6 antibody, while IL-1 signaling was blocked with IL-1 receptor antagonist
(anakinra). Blockade of IL-6 and IL-1 signaling
prior to SEB exposure resulted in a significant suppression of IL-4 reporter activity in the skin-draining lymph nodes but did not influence constitutive
IL-4 reporter activity in a distal lymph node (Figure 6A). We also observed attenuated numbers of
CXCR5+ICOS+ Tfh cells in response to SEB when
IL-1 and IL-6 signaling was blocked (Figure 6B).
Blockade of ST2, the receptor for IL-33, also led
to a significant reduction in IL-4 reporter activity
in vivo (Figure 6C) and a trend toward a reduced
number of Tfh cells (Figure 6D).
In contrast to the findings with SEB, blocking
IL-6 and IL-1 had no effect on peanut-induced
IL-4 reporter activity in draining lymph nodes
(Supplemental Figure 7). However, similar to
that with SEB-induced IL-4 production, neutralizing anti-ST2 antibody administered before
epicutaneous exposure to peanut significantly
suppressed IL-4 reporter activity in skin-drain-

ing lymph nodes but not distal lymph nodes (Figure 7A). ST2 is
expressed on a number of different cell types, including DCs, T
cells, and innate lymphoid cells. We hypothesized that IL-33 from
keratinocytes was modulating the function of DCs. Mice were
treated with isotype or anti-ST2 antibody prior to epicutaneous
exposure to OVA with peanut as adjuvant. DCs were then purified

Figure 5. Effect of CPE or SEB on Th2 and Tfh cells.
4get mice were epicutaneously exposed to PBS,
peanut (CPE), or SEB. One week later, skin-draining
lymph nodes (DLN) and mesenteric lymph nodes
(MLN) were assessed for (A) IL-4 reporter expression
or (B) Tfh markers CXCR5 and ICOS. Representative
plots of IL-4+ or CXCR5+ICOS+ cells of total CD4+ cells in
skin-draining lymph nodes are shown above summary
plots of the mean ± SEM number of cells normalized
per million CD4+ T cells for 3 mice per condition.
*P < 0.05, **P < 0.01.
jci.org   Volume 124   Number 11   November 2014
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Figure 6. Contribution of IL-1, IL-6, and IL-33 to Th2 and Tfh induction
by SEB. 4get mice were pretreated with either isotype control or (A and
B) neutralizing IL-6 antibodies plus IL-1 receptor antagonist or (C and D)
neutralizing anti-ST2 antibody before epicutaneous exposure to SEB.
Draining lymph nodes and mesenteric lymph nodes were harvested 1 week
later. Summary plots of (A and C) IL-4+ cells or (B and D) CXCR5+ICOS+ cells
per million CD4+ T cells are shown. Data are mean ± SEM of 3 mice per
condition. *P < 0.05, **P < 0.01.

from the skin-draining lymph nodes and cocultured with DO11.10
T cells. DCs from peanut-exposed mice induced Th2 priming that
was significantly reduced in mice treated with anti-ST2 antibody
(Figure 7B), indicating that ST2 was acting at or above the level of
the DC, resulting in an altered DC phenotype. We and others have
shown that cholera toxin–driven sensitization by gastrointestinal
DCs is dependent on OX40L expression by DCs (25, 26); however,
blockade of OX40L in the skin DC–T cell cocultures resulted only
in a minor reduction in Th2 cytokine production (Figure 7C). The
lack of significant effect of OX40L neutralization in response to
CPE was also observed using 4get mice in vivo (data not shown).
Together, these data suggest that a diverse set of sensitizing stimuli
at the level of the skin can induce Th2-skewed immune responses
through a ST2-dependent modulation of skin DCs.

Discussion

Peanut is one of the most common foods causing allergic reactions, and peanut allergy is increasing in prevalence in the US (2)
and the UK (31). Peanut allergy, unlike milk or egg allergy, is commonly lifelong and is one of the causes of potentially life-threatening anaphylactic reactions (32, 33). In this report, we identify
novel innate responses to epicutaneous peanut exposure in vivo
that contribute to the generation of Th2-biased adaptive responses
to peanut. Our results point to inherent adjuvant factors in peanut
combined with a nonoral exposure route as being critical to the
development of peanut allergy.
Environmental exposure to peanut is a risk factor for the development of peanut allergy while early dietary exposure of infants to
peanut is associated with low prevalence of peanut allergy (10, 34).
The skin is of particular interest as a route of allergen exposure, since
infant exposure to peanut oil–containing ointments was found to
be a risk factor for peanut allergy in the UK (35). Exposure to wheat
hydrolysates in facial soap has also been reported to be associated
with self-reported wheat allergy (36). We have previously demonstrated that sensitization to milk allergens can be induced via multiple physiological routes in mice, including the epicutaneous route,
but only in the presence of an exogenous adjuvant (19). These previous results suggest that skin exposure is not inherently allergenic
but, given the appropriate immune environment, can result in sen4970
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sitization. For example, the presence of filaggrin mutations, which
confer susceptibility to atopic dermatitis, is a risk factor for peanut
allergy independent of atopic dermatitis (18, 37). This is supported
by preclinical data showing increased susceptibility to sensitization in mice with filaggrin mutations (38). In addition, models of
skin sensitization to food allergens commonly use tape stripping
that causes mechanical injury to promote skin inflammation and
the induction of TSLP and Th2 cytokines that lead to sensitization
(16, 17, 39, 40). Vitamin D analogs, which upregulate TSLP expression in the skin, can also induce sensitization to food allergens via
the skin (22). However, here we show evidence that mice can be
sensitized to peanut or cashew via intact skin in an adjuvant-independent fashion, while soy or green bean extracts, used as control
legume extracts, do not sensitize. This suggests that while the skin
is not inherently sensitizing upon antigen exposure, it is permissive
to sensitization to peanut in the absence of adjuvants, unlike oral
exposure, which leads to tolerance. This finding supports the clinical observations that exposure to peanut through nonoral routes
promotes sensitization (10), while early oral exposure is associated
with lower risk of peanut sensitization (34). Our findings also indicate that this paradigm may not fit all allergens, as it does not apply
to milk (19). The mechanism by which skin, but not gut, exposure
to peanut alone can induce sensitization is not clear but may relate
to features of the resident DCs within each site, such as differential
expression of innate receptors.
Using a series of in vivo approaches, we demonstrated that
peanut elicits an innate response after topical application to intact
skin, followed by an induction of the Th2-priming potential of DCs
in the draining lymph node, leading to the induction of IL-4– and
IL-13–expressing CD4+ T cells. Although there was an induction of
IL-1β and IL-6 from skin and keratinocytes, respectively, and these
cytokines were required for the induction of Th2 and Tfh responses
using the adjuvant SEB, we did not find evidence for a role of IL-1β
and IL-6 signaling in the induction of Th2 responses to peanut.
In both intact mouse skin and human keratinocytes, there was an
upregulation of IL-33 in response to peanut exposure. In keratinocytes this was a late response (24 hours), occurring after the early
peak of proinflammatory cytokines (2 hours), suggesting that IL-33
could be upregulated in response to autocrine signals. Blockade of
ST2, the IL-33 receptor, led to a significant reduction in Th2 cells
in response to epicutaneous peanut exposure. There is growing
evidence for a central role of the IL-1 family member IL-33 or ST2
in the induction of sensitization at multiple tissue sites. Sensitization to dust mite through airway exposure is dependent on ST2 (26,
41), downstream of the innate recognition of dust mite through a
TLR4-dependent mechanism (41). Oral sensitization to peanut
(requiring cholera toxin adjuvant) is also ST2 dependent (26). ST2expressing resident eosinophils in the gastrointestinal tract were
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Figure 7. Peanut induces Th2 polarization through ST2-mediated effects on skin-draining DCs. 4get mice were pretreated with either isotype control or
neutralizing ST2 antibodies before epicutaneous exposure to CPE. One week after exposure, draining lymph nodes and mesenteric lymph nodes were harvested, and (A) IL-4 reporter activity was quantified. Summary data (mean ± SEM) showing number of cells per million CD4+ T cells are shown. n = 3 mice
per condition. *P < 0.05. (B) BALB/c mice were pretreated with isotype control or anti-ST2 antibody prior to exposure to PBS or OVA and CPE. DCs from
skin-draining lymph nodes were cocultured with DO11.10 T cells, and cytokine output was measured. Data are mean ± SEM of 3 independent experiments.
*P < 0.05, compared with isotype control. (C) DCs from skin-draining lymph nodes were isolated after exposure to OVA and CPE and cocultured with
DO11.10 T cells in the presence of anti-OX40L or isotype control antibody. Data are mean ± SEM of 4 independent experiments.

recently reported to be essential for this oral sensitization to peanut by driving CD103+ DCs expressing elevated levels of CD86
and OX40L from the lamina propria to the mesenteric lymph node
(42). Kobayashi et al. recently showed that airway administration
of exogenous IL-1β or IL-33 together with OVA or ragweed extract
could induce IgE production against the allergens (43). Interestingly, IL-1β induced IL-17 production in addition to Th2 cytokines,
while IL-33 induced a more restricted Th2 cytokine induction. Similarly, we observed a broader immunologic impact when mice were
exposed to SEB, which induced Th2 and Tfh cells via IL-1–, IL-6–,
and ST2-dependent pathways, compared with that when mice
were exposed to peanut that induced Th2 cells solely through an
ST2-dependent pathway. ST2 is found on a number of different cell
types, including innate lymphoid cells (44), allergic effector cells
(45, 46), and DCs (47). We did not observe any increase in IL-4 or
IL-13 reporter activity in non-CD4+ T cells after peanut exposure
in the draining lymph nodes. Furthermore, purified DCs from peanut-exposed mice were able to induce Th2 responses from naive
T cells in the absence of any other accessory cells, suggesting
that DCs are sufficient for the induction of Th2-skewed immune
responses to epicutaneous peanut exposure, although the finding
does not necessarily rule out contribution from innate sources of
Th2 cytokines in vivo. Although TSLP can promote sensitization to
allergens via the skin (17, 22, 39), neither mouse skin nor human
keratinocytes upregulated TSLP upon peanut exposure, and sensitization of mice to peanut through the skin was normal in TSLP
receptor–deficient mice (data not shown). This is consistent with
our previous findings and those of other groups that primary sensitization and generation of IgE in response to oral sensitization can
occur through TSLP-independent pathways (26, 48).

Keratinocytes are presumed to be a major source of Th2-
inducing cytokines, including IL-33, IL-25, and TSLP, and, consistent with a keratinocyte source of IL-33 in our model, we
observed that IL33 mRNA expression was regulated by peanut
exposure in human keratinocytes in vitro. The receptor for IL-33
is expressed by DCs, among many other cell types, and treatment
of DCs with IL-33 has been shown to upregulate OX40L expression (49). ST2 may modulate DC function upstream through an
intermediate cell. As an example, gastrointestinal eosinophils
express ST2 and are required for oral sensitization to peanut
through eosinophil peroxidase-dependent modulation of DC
phenotype (42). Recently, two reports identified a skin-draining
DC subset as being critical for the induction of Th2 immunity
(50, 51). The markers CD301b and PD-L2 were identified on
these Th2-inducing DCs, and this DC subset expressed high levels of the IL-33 receptor ST2 (50). Furthermore, these DCs were
required for induction of Th2 responses but not Tfh responses.
In addition to acting on DCs, IL-33 can also be produced by DCs
and act directly on T cells. IL-33 was recently shown to be regulated by IRF-4 in DCs, and DC-derived IL-33 was necessary for
the induction of Th2 immunity (52). In a model of bee venom–
induced Th2 immunity, IL-33 was shown to be central to the
induction of Th2 immunity but via direct actions on T cells rather
than through actions on a DC subset (53). Our data suggest that
ST2 is acting at the level of the DC or higher, rather than directly
on the T cells or through innate lymphoid cells, since neutralization of ST2 in vivo suppressed the ability of DCs to directly
induce Th2 priming after peanut exposure. ST2 also negatively
regulates TLR2 signaling (54), suggesting that ST2 blockade may
have effects beyond neutralization of IL-33 signaling.
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We and others have shown that OX40L on DCs is responsible
for DC-mediated Th2 skewing and sensitization in the gastrointestinal tract (25, 26, 55). In the current studies, OX40L neutralization had only a minor inhibitory effect on DC-driven Th2 cytokine
production in vitro and in vivo, indicating that other mechanisms
for DC-driven Th2 priming must predominate in the skin.
Our data contributes to the growing body of literature showing
that allergens activate innate immunity. Allergy to house dust mite
is one of the most common allergic responses worldwide (56). In the
case of house dust mite, there are several allergens that have protease activity (Der p 1, Der p 3, Der p 6, Der p 9) and a capacity to
bind to lipids (Der p 2) (6, 57, 58). Der p 2 activates the TLR4 signaling pathway by acting as a MD2 mimetic and induces sensitization
in a TLR4-dependent manner that is dependent on presence of LPS
within the preparation (5). In pollens, the presence of pollen-associated lipid mediators that promote Th2 responses has been described
(59). Lectins derived from legumes are able to activate basophils to
release IL-4 and IL-13 (60). Peanut has innate activity on human
DCs, in part through Ara h 1 binding to DC-SIGN (3). Peanut can also
activate complement that may influence adaptive immune responses
(61). We found that purified Ara h 2 was sufficient to induce IgE production in mice, leading to anaphylaxis upon challenge, and could
induce bystander sensitization, demonstrating inherent adjuvant
activity. Ara h 2 is the dominant allergen in peanut, and component
testing has indicated that IgE against Ara h 2 is predictive of clinical
reactivity in patients (21). Interestingly, we did not observe innate
effects of Ara h 2 on human keratinocytes (data not shown), and,
unlike Ara h 1, Ara h 2 is not significantly glycosylated. Innate effects
of peanut extract on human DCs were previously shown to be glycosylation dependent, and purified Ara h 2 did not induce a Th2-skewing phenotype in human DCs (3). Thus, the molecular mechanism
by which Ara h 2 may induce bystander sensitization is unclear. It
was shown, using timothy grass extract, that Th2-inducing activity
could be discriminated from IgE binding, and several novel proteins
were identified that were capable of Th2-inducing activity but were
not recognized by IgE (62). Similar approaches are needed to identify all potential T cell modulatory fractions of peanut that may be
distinct from the dominant allergens.
In summary, we have shown that the skin is permissive to allergic sensitization on exposure to peanut without additional adjuvants
or tissue damage and that peanut induces Th2 skewing through a
DC-autonomous pathway that is ST2 dependent. We contrast this
with sensitization induced by the superantigen SEB, which induces
both Th2 skewing and Tfh induction through IL-1– and IL-6–dependent as well as ST2-dependent pathways. Our data provide a mechanistic explanation for the epidemiologic observations that nonoral
household exposure to peanut is a risk factor for peanut allergy. Furthermore, this model of adjuvant-independent sensitization to peanut provides a clinically relevant model of peanut allergy that can be
used to dissect the molecular basis of peanut allergenicity.

Methods

Antigens and adjuvants. Defatted CPE was prepared as previously
described (24). Briefly, roasted peanuts were shelled, ground to a
paste, defatted with acetone, dried overnight, and then extracted
with PBS with complete protease inhibitor (Roche). Soy extract was
prepared from soy flour (Arrowhead Mills). Green bean and cashew
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extracts were prepared as described above. ALA and OVA (grade
V) were purchased from Sigma-Aldrich. Purified Ara h 1 and Ara
h 2 for in vivo studies and basophil activation tests were prepared
as previously described (63, 64). Extracts used in cell culture were
purified from endotoxin using Detoxi-Gel columns (Pierce). SEB
was from Toxin Technologies. Cholera toxin was from List Biological Laboratories.
Mice. C3H/HeJ and BALB/c mice were obtained from National
Cancer Institute, and C3H/HeOuJ mice were obtained from Jackson
Laboratories. 4get (28) and DO11.10 mice (Jackson Laboratories) were
maintained as breeding colonies at Mount Sinai. IL-13eGFP (29) mice
were originally developed by Andrew McKenzie (MRC Laboratory of
Molecular Biology, Cambridge, United Kingdom) and provided by
Paul Bryce (Northwestern University, Chicago, Illinois, USA).
Epicutaneous sensitization of mice. Six- to eight-week-old female
mice were anesthetized, and abdominal fur was removed with depilatory cream (Veet; Reckitt Benckiser), immediately followed by exposure to antigens (1 mg crude extract or 0.1 mg purified antigens) in
50 to 100 μl PBS spread thinly on the abdominal skin to dry. SEB or
cholera toxin were applied at a dose of 10 μg. In some experiments,
antigens were applied to the ear pinnae. Mice were exposed weekly
for a total of 6 exposures and challenged a minimum of 1 week after
the last exposure.
Allergen challenge and assessment of anaphylaxis. Mice underwent
an oral challenge to allergen (50 mg ALA or OVA) and were observed
for 30 minutes following challenge. Body temperature was measured
before and 30 minutes after challenge. For extracts, mice were challenged by intraperitoneal route with 100 μg antigen and followed for a
further 30 minutes prior to measuring temperature with a rectal thermometer (WPI Instruments).
Cytokine neutralization. During neutralization experiments, mice
were pretreated with neutralizing anti–IL-6 (0.5 mg) or isotype antibody (BioXCell) together with the IL-1 receptor antagonist anakinra
(0.1 mg per mouse, provided by Raphaela Goldbach-Mansky, NIH,
Bethesda, Maryland, USA). IL-33 receptor (ST2) was blocked with
neutralizing anti-ST2 (20 μg) or isotype control antibody (R&D Systems). Mice were then epicutaneously exposed to OVA and SEB or
CPE. Mice undergoing IL-6/IL-1 or ST2 neutralization received half
of the initial antibody amount administered every other day for 7 days.
OX40L was blocked with anti-OX40L (0.2 mg per mouse) or isotype
control antibody (R&D Systems) twice in 1 week.
Flow cytometry. One week after epicutaneous exposure mice were
sacrificed, and cells from skin-draining lymph nodes and mesenteric
lymph nodes were harvested, washed, and stained with anti-mouse
CXCR5 (BD Biosciences), anti-mouse CD44 (Biolegend), antimouse CD4 (eBioscience), and anti-mouse ICOS (eBioscience), in
the presence of FcBlock (eBioscience). Cells were acquired on a BD
LSR Fortessa cytometer (BD Biosciences). Data were analyzed using
FlowJo software (TreeStar Inc.).
Skin gene expression. CPE (1 mg) applied on the left ears and right
ears of mice was used as negative control. Ears were harvested 2, 4,
and 24 hours after the CPE application. Total RNA was isolated with
Trizol (Invitrogen, Life Technologies), followed by RNA clean up with
the RNeasy Mini Kit (Qiagen).
Human keratinocytes. Human epidermal keratinocytes (neonatal cells, Invitrogen, Life Technologies) were cultured using EpiLife
medium with growth supplements (all from Gibco, Life Technologies).
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Cells were seeded in 24-well plates and stimulated with CPE or soy
extract. Cells were recovered at several time points for RNA isolation
with the RNeasy Mini Kit (Qiagen).
Bone marrow–derived DCs. Bone marrow cells were collected
from femurs and cultured for 10 days in RPMI 1640 with l-glutamine
(Gibco, Life Technologies), supplemented with 10% fetal bovine serum
(Gemini Bio-products), penicillin/streptomycin (Gibco, Life Technologies), 50 μM 2-Mercaptoethanol (Sigma-Aldrich), and 20 ng/ml
GM-CSF (Peprotech). At day 10, bone marrow–derived DCs were collected and resuspended in complete RPMI at a concentration of 5 × 105
cells per ml. Cells were stimulated for 3 hours with CPE (50 μg/ml),
followed by RNA isolation with the RNeasy Mini Kit (Qiagen).
Real-time PCR. RT-PCR was performed, starting from 1 μg total
RNA, using SuperScript II Reverse Transcriptase (Invitrogen, Life
Technologies). cDNA was amplified using the Power SYBR Green
PCR Master Mix (Applied Biosystems, Life Technologies) and run on
an Applied Biosystems 7300 Real-Time Detection System, using the
following primers: mouse Il6, F, TTCCATCCAGTTGCCTTCTTG;
R, GGGAGTGGTATCCTCTGTGAAGTC; mouse Il1b (65), F,
TTGACGGACCCCAAAAGAT; R, GAGCGCTCACGAACAGTTG;
mouse Il10 (25), F, TGCTATGCTGCCTGCTCTTA; R, TCATTTCCGATAAGGCTTGG; mouse Ox40l (25), F, CCCTCCAATCCAAAGACTCA; R, ATCCTTCGACCATCGTTCAG; mouse Il33, F, ATCGGGTACCAAGCATGAAG; R, GACTTGCAGGACAGGGAGAC;
mouse Tslp (48), F, GAGAGAAATGACGGTACTCA; R, CTACAGTTAGGTTTGCCCTA; mouse Il25, F, TGTTGCATTCTTGGCAATGATC; R, GACTGCAGCCCTCCTGGAT; human IL6, F, AAAGAGGCACTGGCAGAAAA; R, CAGGGGTGGTTATTGCATCT;
human IL33, F, GAGCTAAGGCCACTGAGGAA; R, TGGGCCTTTGAAGTTCCATA.
GADPH and β-actin were used as the housekeeping genes. Relative quantification was performed using the comparative threshold
cycle method (2–ΔΔCt). The changes in gene expression were calculated
with respect to the untreated cells. All amplifications were carried out
in duplicates.
Antigen presentation assay. Antigen presentation assay was performed as previously described (19). BALB/c mice were exposed to 10 mg
OVA in the presence or absence of 1 mg CPE. After 24 hours, DCs were
purified from inguinal lymph nodes by using CD11c microbeads (Miltenyi Biotec). DCs were cultured at a ratio of 1:5 with DO11.10 CD4+
T cells. After 72 hours, cells were restimulated with anti-CD3/CD28,
supernatants were harvested, and cytokines were measured by ELISA
according to manufacturer’s instructions (all from eBioscience).
In neutralization experiments, anti-ST2 was injected prior to
exposure with OVA and CPE, as described above. For the OX40L neu1. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment.
J Allergy Clin Immunol. 2014;133(2):291–307.
2. Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut,
tree nut, and sesame allergy: 11-year follow-up.
J Allergy Clin Immunol. 2010;125(6):1322–1326.
3. Shreffler WG, et al. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of
dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol.
2006;177(6):3677–3685.

tralization, DCs were cocultured with T cells in the presence of antiOX40L (10 μg/ml) or isotype control antibody (R&D Systems).
Immunoblotting. CPE (15 μg/cm) was separated on SDS-PAGE
(NuPage MES, 4% to 12% ZOOM gels, Invitrogen). The protein was
transferred onto nitrocellulose membranes (Bio-Rad). After blocking,
membranes were incubated with diluted human sera (1:50), followed
by detection with mouse Anti-Human IgE-Alkaline Phosphatase
(Sigma-Aldrich), alkaline phosphatase chemiluminescent substrate
(CDP-Star, Sigma-Aldrich), and exposure to film (30–90 minutes).
Alternatively, membranes were incubated with diluted mouse sera
(1:20), followed by detection with sheep anti-mouse IgE (Binding
Site), donkey anti-sheep HRP (Binding Site), and HRP substrate (Millipore). The blot was exposed for 1 to 5 minutes.
Basophil activation tests. Basophil activation tests were performed as previously described (66). Blood was diluted in RPMI and
incubated at 37°C for 90 minutes with extracts or purified allergen
at 50 μg/ml except where indicated. Red blood cells were lysed, and
cells were stained with CD49b and IgE to detect the population of
basophils, after gating out T and B cells with CD3/CD19 staining.
CD200R was used as basophil activation marker (all antibodies were
from eBioscience).
Statistics. Statistical analyses were performed using GraphPad Prism
software, version 6.0e (GraphPad). Two-tailed Student’s t test or 2-way
ANOVA followed by Bonferroni analysis were used for determining
statistical significance (P < 0.05). Results are expressed as mean ± SEM.
Study approval. All animal procedures were approved by the Institutional Animal Care and Use Committee of the Icahn School of Medicine at Mount Sinai. Clinical specimens were provided by the Jaffe
Food Allergy Resource Initiative. Inform consent was obtained for all
the studied subjects. All the procedures were approved by the Institutional Review Board at Mount Sinai School of Medicine.
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